NRIX — Nurix Therapeutics Share News
0.000.00%
Last trade - 00:00- $2.73bn
- $1.68bn
- $83.98m
Nurix Therapeutics Inc expected to post a loss of 80 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Acelyrin, Endeavour Silver, B2Gold
U.S. STOCKS ON THE MOVE-Hyatt, Fortrea, China ADRs
Nurix Therapeutics rises after U.S. FDA lifts hold on cancer study
Brief: Nurix Therapeutics Announces U.S. FDA Lifts Partial Clinical Hold On Nx-2127 Phase 1 Trial
U.S. RESEARCH ROUNDUP-Albemarle, Dropbox, Tyler Technologies
Nurix Therapeutics Inc reports results for the quarter ended in November - Earnings Summary
Nurix Therapeutics Inc expected to post a loss of 57 cents a share - Earnings Preview
Nurix Therapeutics Inc expected to post a loss of 57 cents a share - Earnings Preview
Brief: Nurix Therapeutics Receives U.S. FDA Fast Track Designation for NX-5948 for the Treatment of Relapsed or Refractory CLL and SLL
Brief: Nurix Therapeutics Outlines 2024 Strategic Priorities
Brief: Nurix Therapeutics Presents Positive Clinical Data from Its Novel Bruton’s Tyrosine Kinase Degrader Programs, NX-5948 and NX-2127
U.S. RESEARCH ROUNDUP-Domino's Pizza, Duolingo, Tractor Supply Co
Nurix Therapeutics Inc reports results for the quarter ended in August - Earnings Summary
Nurix Therapeutics Inc expected to post a loss of 76 cents a share - Earnings Preview
Nurix Therapeutics Inc expected to post a loss of 76 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Kodiak Sciences, Intensity Therapeutics, Inovio Pharma
U.S. STOCKS ON THE MOVE-Kodiak Sciences, Intensity Therapeutics, Inovio Pharma
U.S. STOCKS ON THE MOVE-Nurix Therapeutics, Designer Brands